Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Sun Pharma Launches Ezallor Sprinkle (Rosuvastatin) in the U.S. for People Who Have Difficulty Swallowing

Posted On: 2019-07-15 08:31:19

Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" including its subsidiaries and/or associate companies) today announced the U.S. launch of Ezallor Sprinkle™ (rosuvastatin) capsules for the treatment of three types of elevated lipid disorders in people who have difficulty swallowing, a problem that is estimated to affect approximately 30-35% of long-term care residents.

Ezallor Sprinkle is indicated as an adjunct to diet for the treatment of adult patients with hypertriglyceridemia, as an adjunct to diet for the treatment of adult patients with primary dysbetalipoproteinemia (type III hyperlipoproteinemia), and as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or as monotherapy if such treatments are unavailable, to reduce LDL-C, total cholesterol, and ApoB in adult patients with homozygous familial hypercholesterolemia. Ezallor Sprinkle has not been studied in Fredrickson type I and V dyslipidemias.

"With the introduction of Ezallor Sprinkle, Sun Pharma continues our commitment of providing a portfolio of alternative formulation products to address the needs of people who have difficulty swallowing, which is especially prevalent among residents in long-term care facilities," said Abhay Gandhi, CEO, North America, Sun Pharma. "These patients often encounter more medication errors and challenges with medication administration as compared to long-term care residents who do not have difficulty swallowing."

"The risk of medication errors increases when people have difficulty swallowing, due to crushing of medicines that shouldn't be crushed, or from residual medication left over in crushing devices," said Dr. Chris Chappel, certified Medical Director, Chappel Senior Care and Chappel Group Research. "This formulation will help in administering medication for patients with common types of elevated lipid disorders, especially in the geriatric population."

Ezallor Sprinkle is formulated as extended-release-coated pellets that may be sprinkled over soft food such as applesauce, can be swallowed whole, or administered via a nasogastric tube to facilitate long-term, once-daily administration. Ezallor Sprinkle joins Kapspargo Sprinkle™ (metoprolol succinate) extended-release capsules as the second product in the Sun Pharma portfolio designed for individuals in long-term care.

Ezallor Sprinkle is contraindicated in patients with any known hypersensitivity to rosuvastatin, which may include rash, pruritus, urticaria, and angioedema; patients with active liver disease, which may include unexplained persistent elevations of hepatic transaminase levels, and females who are pregnant or breastfeeding. In the controlled clinical trials database, the most common adverse reactions with rosuvastatin were headache, myalgia, abdominal pain, asthenia, and nausea.

Shares of SUN PHARMACEUTICAL INDUSTRIES LTD. was last trading in BSE at Rs.407.7 as compared to the previous close of Rs. 398.1. The total number of shares traded during the day was 702676 in over 8352 trades.

The stock hit an intraday high of Rs. 411.2 and intraday low of 397.3. The net turnover during the day was Rs. 284851721.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

CNG supply, CNG-run vehicles and D-PNG supply launched in Ranchi

Insilco Ltd announces shut down of plant on high inventory

Ind-Ra revises rating outlook of Dynamatic Technologies Ltd

US FDA Inspection at Alkem's two manufacturing facilities

Cupid Ltd receives order of Rs. 4.95 crores

Trident Limited won 'Madhya Pradesh State Level 8th Kaizen Competition' Award

Supershakti Metaliks Ltd Board approves 1:1 Bonus Issue

Advik Laboratories Ltd to sell plant to pay for OTS with Indian Overseas Bank

Galaxy Surfactants' 'Aapda Rahat' CSR project extend flood relief aid to 1,000 families in Sangli

NHPC signs agreement with Assam Government for 2000 MW Hydro Power Project

NCL Industries Ltd to form JV in China

ICRA reaffirms ratings of Endurance Technologies Ltd

Bandhan Bank launches credit cards, in partnership with Standard Chartered Bank

IFFCO to invest Rs. 262.15 crore in Triumph Offshore Pvt. Ltd.

Wockhardt Ltd receives GMP compliance certificate for Ankleshwar unit

Thomas Cook India brings Domestic Tourism to the forefront

Hindustan Oil Exploration Company Ltd clarifies on stake sale by KMPs

Maruti Suzuki to proactively recall 40,618 WagonR (1 litre) vehicles

Sundaram-Clayton Ltd's plants to work only for 5 days in a week

Nilkamal Bito Storage Systems Pvt Ltd is now wholly owned subsidiary of Nilkamal Ltd

TVS Motor Company supports flood-affected states across India

Ishan Dyes & Chemicals Ltd allots 47,03,447 shares on rights basis

63 moons wins MPID case in Bombay HC, Court rules NSEL is not financial establishment

Brickwork Ratings revises ratings of Sical Logistics Ltd

TCS iON IntelliGem to Help School Students Build 21st Century Skills

Glenmark Pharmaceuticals receives ANDA approval for Fulvestrant Injection, 250 mg/5 mL (50 mg/mL)

Ethos Ltd opens new store at Phoenix Maret City, Velachery, Chennai

MEP Infrastructure Developers receives LOA for BOT project

India Ratings Places Shree Renuka Sugars on RWN

Infosys and University of Illinois Urbana-Champaign Enter a Strategic Partnership for Precision Medicine

Dabur India Ltd updates on new step down Subsidiary Company

Bimetal Bearings Ltd announces re-alignment of production

Amazon to acquire 49% in Future Coupons Ltd

Pidilite unveils state-of-the-art adhesive manufacturing plant in Bangladesh

HDFC Bank Ltd appoints Mr. Srinivasan Vaidyanathan as CFO

New Version of TCS iCMC™ Solution to Help Enterprises Accelerate their Cloud Journey

Kamdhenu Ltd starts partial manufacturing operations at paints factory, Alwar

Shreeji Translogistics Ltd Board to consider Interim Dividend & Bonus Issue

5paisa Capital Ltd allots shares on rights basis

KIOCL contributes to Chief Minister's relief fund

CARE downgrades ratings of Shivam Autotech Ltd

Commercial Syn Bags Ltd Board approves Dividend of Rs. 0.80

CRISIL revises outlook on long-term rating of BHEL

Gillette India Ltd appoints Mr. Gagan Sawhney as Additional Director

JK Super Cement announces association with Dabang Delhi as Team Title sponsor in Pro Kabaddi League 2019

Federal Bank Ties Up with Lulu Money, Hong Kong to Offer Instant Money Transfer to India

ITC Sunfeast Cup returns to Ladakh for an exciting second edition

Premier Ltd announces OTS of Rs. 31.17 crore for pending dues with Corporation Bank

Celebrity Fashions Ltd completes sale of property at GST Road, Chennai for Rs. 17 crores

Lupin launches Fluoxetine Tablets USP on receipt of US FDA approval







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019